Physician profile
Jonathan J Dykstra
NPI 1255357935
$1,042.02
in general payments reported to CMS, 2019-2025
13 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2021: $72.09 · 2022: $220 · 2023: $50.97 · 2024: $270 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $208.29 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Urgo Medical North America, LLC | $205.91 | 2024 | Urgok2 |
| Organogenesis INC. | $202.52 | 2019-2022 | |
| Integra Lifesciences Corporation | $156.00 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Osiris Therapeutics INC. | $68.77 | 2019 | |
| Cardiovascular Systems INC. | $37.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.53 | 2019 | |
| Abbvie INC. | $35.77 | 2023 | Liletta |
| Globus Medical, INC. | $21.23 | 2025 | Senza |
| Left Coast Surgical INC | $20.46 | 2025 | |
| Tactile Systems Technology INC | $18.84 | 2022 | |
| Smith+Nephew, INC. | $17.72 | 2019 | |
| Convatec INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dykstra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.